Wednesday, December 24, 2014

Very Important Patient (VIP): Daiquan


Daiquan lives with his family in Indiana. He was only 23 when he was diagnosed with a rare cancer called Squamous Cell Carcinoma of the Nasopharynx, stage IV. He entered a clinical trial in March 2013, it was his only treatment option. In November 2014 he received the news that is cancer free!  

"I'm truly blessed to be able to say I'm CANCER FREE!!!!! I have to give thanks to USDC Cancer Center and everyone there that had faith. I must give thanks to the Lazarex Cancer Foundation as there's no way I would have made it without their help. To everyone that donates to their program - Thank You so very much and may God bless all of you! I pray that everyone has very safe and Happy Holidays!!!
Daiquan

The Best Gift Ever

 
Dear Friends,
It's no secret that in the midst of all the holiday hustle, the spirit of goodwill can seem hard to find. We get so caught up in our pre-holiday activities that we don't notice the goodness and kindness that is happening around us. I am happy to say that at Lazarex we experience acts of goodwill everyday through our sponsors, donors, volunteers, fundraising participants and the many letters of gratitude that we receive from patients and their family members.  
    
Your support of Lazarex Cancer Foundation has given hope and life to so many. Thanks to you, over 900 Lazarex-supported patients have participated in clinical trials that have led to FDA approval of more than a half-dozen cancer fighting drugs!  Your gift not only helps cancer patients in need now, it is reaching their families and loved ones, as well as future generations. 
 
Here is one example of your gifts in action: In November, Daiquan, a Lazarex VIP (Very Important Patient), got the news that he is cancer free thanks to the clinical trial treatment he receives!

With your support we can continue to help end stage cancer patients engaged in a fight for life. Please consider a contribution to Lazarex when making your year-end donations.  

As you celebrate this holiday season, may you and your loved ones receive the gifts of connection, grace and healing. May the spirit of goodwill prevail and gladden your heart.   
 
Sincerely,
Dana Dornsife
President,
Lazarex Cancer Foundation
www.lazarex.org

Tuesday, December 16, 2014

They walked, they ran, they gobbled their way to the finish line in the 2014 Thanksgiving Turkey Run

They walked, they ran, they gobbled their way to the finish line in the 2014 Thanksgiving Turkey Run. This Thanksgiving was Lazarex Cancer Foundation’s first year as a benefiting and participating charity in the Forma Gym 22nd Annual Turkey Trot in Walnut Creek, CA.

This Thanksgiving was Lazarex Cancer Foundation’s first year as a benefiting and participating charity in the Forma Gym 22nd Annual Turkey Trot in Walnut Creek, CA.

We were the sponsor for the Kids Fun Run’s. It was a great morning to spend with a large community of friends and families for the benefit of local nonprofits. It was a great way to kick off a day of celebration and gratitude.

The event had over 7,000 registered runners this year! It was largest festival venue by far. In 2015 there will be brand new courses in all events to accommodate the growing number of participants.

Look for us next year – we’ll be there!

Tuesday, July 29, 2014

Breaking down barriers to health care

Mass. General’s Dr. Karen Winkfield says that to improve access to health care and clinical trials, the solution has to be sustainable.
When Dr. Karen Winkfield leaves Massachusetts General Hospital to discuss health issues at Boston-area churches and clinics, she refers to her message as the “triple A:” awareness, advocacy, and ambassadorship. Read more

Tuesday, May 6, 2014

The Next Best Thing

The Next Best Thing
by Maida Broudo
One woman’s life changing quest to honor the memory of her father brings hope and inspiration to others. 
How can anyone “top” running 52 marathons in the span of 52 weeks to raise money and awareness for pancreatic cancer? Julie Weiss, 44, also known as the Marathon Goddess, has figured it out.
Ms. Weiss has a “flower child” like quality and a contagious spirit. When she smiles, it comes from her toes-literally. Perhaps that is why Lupe Romero-De La Cruz, 52, and a pancreatic cancer patient, ran the last mile of the 52nd marathon with Julie, even though she has just had surgery three months earlier. Ms. Romero-De La Cruz had been given 6 months to live. Through Julie’s inspiration and dedication, De La Cruz trained for and completed the Los Angeles Marathon on March 9th of this year.
In 2012, Ms. Weiss decided to run 52 marathons in 52 weeks in memory of her father, Maurice Weiss who died just one month after being diagnosed with pancreatic cancer. “It was like a death sentence, “ said Ms. Weiss. “I just had to do something to help.”
Helping is exactly what Julie is doing. Her marathon endeavors provide significant impact for both the Maurice Weiss Pancreatic Cancer Fund, and the Lazarex Cancer Foundation, with whom she is now is in partnership. As an ambassador for Lazarex’s “Team for Life” endurance division twenty percent of the funds raised by Ms. Weiss will be allocated to help pancreatic cancer patients have access to breakthrough treatments through FDA clinical trials with the rest going to the foundation’s broader mission.
Ironically, the Founder and President of Lazarex Cancer Foundation, Dana Dornsife, lost her brother in law, Mike Miller, then 46 years old, to pancreatic cancer. This spurred her to find a way to help others facing advanced cancer and searching for some sort of hope when they have been told there are no other options. As of 2013, the foundation has raised over 5 million dollars and provided 312 patients in 43 states and 6 countries, with financial assistance, making it possible for them to participate in clinical trials.
Pancreatic cancer is the 4th leading cause of cancer related death, most patients die within 2 years of their diagnosis. Despite this grim statistic, it is the most under funded of all cancer research. To date, Ms. Weiss has raised nearly $250,000, and is not stopping until she reaches $1 million.
Though the 52 marathons are behind her, Ms. Weiss continues to run and raise funds. Just this year alone she ran the LA Marathon and will run the Boston Marathon, the Big Sur International Marathon, the San Francisco Marathon and the TCS New York City Marathon as a member of Team for Life for the Lazarex Cancer Foundation.
For Ms. Weiss, the “next big thing” is seeing 2 pancreatic survivors winning their battle and running their own half marathons to prove it. Roberta Luna, 56 and an 11-year pancreatic cancer survivor, just competed a half-marathon. Ms. De la Cruz, as already mentioned, completed a full marathon just this past March. “These women have hearts of gold, and are full of determination, life and love,” said Ms. Weiss. “That is really what it’s all about!”
Pre-Race Screening of Spirit of the Marathon II, April 26, Monterey, CA
During the Big Sur International Race weekend Ms. Weiss will be a host/guest at a pre-race screening of the Spirit of the Marathon II film in which she was featured as one of seven runners at the Rome Marathon. This was the beginning of her quest to run one marathon a week for a year to honor the memory of her father. Proceeds benefit the Maurice Weiss Pancreatic Cancer Fund.  For information and tickets go to www.Lazarex.org.
Learn more about Team for Life at www.teamforlifelcf.org and Julie Weiss, Marathon Goddess, at www.marathongoddess.com.
About the author:
Maida Broudo has worked with cancer patients since she was 19, at the Massachusetts General Hospital, the Dana Farber Cancer Institute, and the National Cancer Institute, where clinical trials were de rigeur. She spent much of her career with patients-mostly in delivering Radiation Therapy, but also as a "navigator" helping them find the best team for their diagnosis.
As a marathon runner, who has run 10 Boston Marathons to raise money for cancer research, Maida found an instant love for the Lazarex Cancer Foundation when introduced by her aunt and uncle. She felt it a match of her own heart and could not look away.
Maida is currently a health journalist, consultant, and yoga teacher. She also teaches at Harvard Medical School and tutors nursing and allied health professionals. It is her very deep pleasure to be involved with Lazarex, and looks forward to making a difference for cancer patients.

Friday, March 14, 2014

Anderson Carpet and Linoleum Sales, Oakland, CA – 2013 18th Annual Classic Golf Tournament (fundraiser)

Lazarex Cancer Foundation Dana Dornsife and Susan Sappington receiving the Big Check for $14,363 from Tom Christophe, Cathy Schaller and Joe Christophe of Anderson Carpet and Linoleum Sales, Oakland, CA. Thank you, thank you for choosing Lazarex Cancer Foundation to be the benefiting charity for your 18th Annual Classic Golf Tournament fundraiser! A special thanks to the 130 players and tournament sponsors who so generously gave to the cause.

Thursday, January 9, 2014

Green tea reduces risk of blood cancers by 42 percent

 by: Paul Louis

 A Japanese green tea study has determined impressive results regarding the reduction of blood and lymph cancers. Tohoku University researchers found a 42 percent reduction for blood cancers and 48 percent reduction for lymph cancers with high green tea consumption.

To arrive at these results, they analyzed the age, gender, lifestyle and health of 40,000 Japanese over a ten-year period. The epidemiological studies (statistical observations over time) of Japan have been bolstered with western clinical application and lab studies that revealed interesting observations.

For example, the Mayo Clinic of Minnesota fed leukemia patients large doses of GTE's (green tea extracts) and discovered immediate benefits in their patients. However, the doctors consider GTE's a helpful adjunct to orthodox cancer treatments. They declined the notion of using GTE's exclusively or in conjunction with other natural cancer treatments.

Researchers in Spain and England isolated the mechanics of green tea's inhibition of cancer cells. Their research was published back in the March 2005 issue of Cancer Research. They found that ECGC, an extremely abundant catechin in green teas inhibits the enzyme dihydrofolate reductase (DHFR).

Catechins are active polyphenolic antioxidant metabolites in green tea. The DHFR enzymes they inhibit are needed by cancer cells to proliferate. Upon closer scrutiny of green tea ECGC, they determined that its molecular structure closely resembles that of the cancer drug methotrexate used in chemotherapy.

The good news is that the binding properties of ECGC is not as intense as the drug methotrexate. Therefore, the side effects of green tea are minimal. But there is one situation where green tea's ECGC binding to DHFR can be detrimental: ECGC binding to DHFR can inhibit the folic acid needed by women pregnant in their first trimester. This situation has been shown to increase the risk of her child being born with spina bifida or other fetal neurological disorders.

Because of this, it is recommended that women curb their green tea consumption just prior to pregnancy and during the first trimester.

Source: Natural News